|Title:||Composition for sustained release of human growth hormone|
|Abstract:||The method of the invention for producing a composition for the sustained release of biologically active hGH includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles.|
|Inventor(s):||Johnson; OluFunmi Lily (Cambridge, MA), Ganmukhi; Medha M. (Carlisle, MA), Bernstein; Howard (Cambridge, MA), Auer; Henry (Chicago, IL), Khan; M. Amin (Downington, PA)|
|Assignee:||Alkermes Controlled Therapeutics, Inc. (Cambridge, MA)|
Patent Claim Types:|
see list of patent claims
|Composition; Use; Delivery;|
Field: Medical technology
Back Citations: 28th percentile
Forward Citations: 4th percentile
|Patent Number||Expiration Date|
|6,051,259||April 18, 2012|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.